Cypress Capital’s HCA Healthcare HCA Stock Holding History

Cypress Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-53	Closed	-$17K	–	193
2024 Q2	$17K	Buy	+53	New	+$17.2K	﹤0.01%	165

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cypress Capital's HCA Position: Q3 2024 in Review

Cypress Capital sold out of HCA Healthcare (HCA) in Q3 2024, closing a stake of 53 shares — an estimated $17K sold.

Cypress Capital first reported a position in HCA in Q2 2024 and held it in 1 quarter. The position peaked at $17K in Q2 2024. 1,202 funds tracked by Wall St. Rank hold HCA as of Q3 2024.

Cypress Capital reported no remaining HCA Healthcare position as of Q3 2024 after selling out during the quarter.
Cypress Capital sold 53 HCA Healthcare shares in Q3 2024, an estimated $17K.
Cypress Capital first reported a position in HCA Healthcare in Q2 2024 and held it in 1 quarter.
Cypress Capital's HCA Healthcare position peaked at $17K in Q2 2024.
1,202 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.